Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

Exhibit 10.12

 

ASSIGNMENT OF PATENT

 

This Assignment, made and entered into on this 30th day of December, 2002 by and between F. Nicholas Franano, an individual residing in Kansas City, Missouri (“Assignor”), and Proteon Therapeutics, L.L.C., a Missouri Limited Liability Company (“Assignee”).

 

WITNESSETH THAT:

 

WHEREAS, Assignor is the owner of a certain valuable invention entitled “Local, Transcatheter Delivery of Pretenses to Reopen Obstructed Biological Conduits” (hereinafter referred to as “Invention”), said Invention disclosed and/or claimed in U.S. Provisional Patent Application Serial No. 60,155,938 filed on September 24, 1999, U.S. Patent Application Serial No. 09,669,051 filed on September 24, 2000 and International PCT Application Serial No. PCT;US00/26237 filed on September 24, 2000 (hereinafter referred to as “Patent Rights”); and

 

WHEREAS, Assignor wishes to transfer ownership in said Invention and Patent Rights to Assignee to facilitate the further development and marketing of said Invention.

 

NOW THEREFORE, in consideration of the sum of Ten Dollars ($10.00) and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Assignor does hereby assign all of Assignor’s right, title, and interest as Inventor in and to the Invention and in and to the Patent Rights, including, but not limited to all patent amendments and/or changes made to finally obtain a Patent and by its signature hereon, Assignee from this date forward agrees to bear all additional charges and costs, if any, associated with the processing of the Patent Application and agrees to save Assignor harmless from any such costs and / or expenses.

 

IN WITNESS WHEREOF, the parties hereto have executed this Assignment on the day and year first above mentioned.

 

 

 

/s/ F. Nicholas Franano

 

 

F. Nicholas Franano, Assignor

 

 

 

 

 

 

 

 

Proteon Therapeutics, L.L.C.

 

 

 

 

 

 

 

By:

/s/ F. Nicholas Franano

 

 

F. Nicholas Franano, Managing Member